Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIM | AMGN | VRTX | BMY | GILD |
| Company | Alimera Sciences Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 5.55 | 277.00 | 461.35 | 58.30 | 91.60 |
| High | 5.56 | 279.04 | 467.06 | 59.22 | 94.27 |
| Low | 5.53 | 273.15 | 457.96 | 58.23 | 91.60 |
| Last | 5.54 | 274.33 | 459.92 | 58.84 | 93.39 |
| Change | -0.01 | -3.93 | -4.06 | +0.47 | +1.80 |
| % Change | -0.18% | -1.41% | -0.88% | +0.81% | +1.97% |
| Volume | 2,679,900 | 3,185,295 | 1,183,837 | 8,115,271 | 12,428,428 |
| 20-Day Average Volume | 1,695,820 | 4,607,810 | 1,370,727 | 11,342,033 | 7,814,602 |
| Previous Close | 5.55 | 278.26 | 463.98 | 58.37 | 91.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.54 | 291.29 | 471.54 | 58.13 | 92.10 |
| 20-Day Raw Stochastic | 93.13% | 23.46% | 19.93% | 68.50% | 57.02% |
| 20-Day Relative Strength | 55.81% | 32.12% | 45.56% | 59.38% | 59.17% |
| Weighted Alpha | +13.93 | -6.45 | +21.68 | +26.21 | +28.19 |
| Today's Opinion | 48% Buy | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 72% Sell | 8% Sell | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.36% since 09/06/24 | -2.05% since 11/27/24 | -1.00% since 11/27/24 | -0.73% since 11/27/24 | +1.06% since 11/27/24 |
| Low | 4.32 on 09/10/24 | 273.15 on 12/05/24 | 450.00 on 12/04/24 | 57.59 on 12/04/24 | 89.86 on 12/04/24 |
| High | 5.57 on 09/09/24 | 283.64 on 11/29/24 | 470.93 on 11/29/24 | 60.09 on 12/03/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -1.07% since 08/13/24 | -14.08% since 11/05/24 | -7.99% since 11/05/24 | +5.17% since 11/05/24 | +3.51% since 11/05/24 |
| Low | 4.32 on 09/10/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 5.63 on 09/06/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +73.67% since 06/13/24 | -15.42% since 09/05/24 | -1.85% since 09/05/24 | +18.15% since 09/05/24 | +18.56% since 09/05/24 |
| Low | 3.01 on 06/20/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 78.26 on 09/06/24 |
| High | 5.65 on 06/24/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +45.03% since 03/13/24 | -10.75% since 06/05/24 | -4.79% since 06/05/24 | +42.68% since 06/05/24 | +46.20% since 06/05/24 |
| Low | 2.77 on 06/10/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 5.65 on 06/24/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 290,235 | 149,573,936 | 119,488,304 | 118,384,688 | 114,145,504 |
| Shares Outstanding, K | 52,389 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 80,750,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -20,130,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 27,000,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -3,310,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.25 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 08/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/24/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 0.00 | 50.16 | 20.88 |